Rating : 9,8/10 (⭐⭐⭐⭐⭐)
🔹Professor Wick, as Medical Director of the Department of Neurology, has made exceptional contributions as a physician, scientist, and manager.
🔹Given the current challenges in strengthening science within university medicine, we are delighted that he has taken on this important position, which allows him to highlight the subject and provide new impetus for the political discussion," says Professor Dr. Ingo Autenrieth, Chief Medical Director of the UKHD.
🔹Professor Wick not only brings outstanding scientific expertise in the fields of neurology and oncology but also political experience from years of committee work and leadership roles, for example, with the German Cancer Society and the European Association for Neurooncology.
🔹The Science Council, for instance, significantly shapes the German scientific landscape within the framework of the Excellence Strategy. Therefore, it is very encouraging that Professor Wick, a well-connected scientist and physician who is intimately familiar with the unique challenges of university medicine, has been elected to the position of chairman.
🔹Since January 2007: Ärztl. Direktor und Professor für klinische Neuroonkologie,
Abt. Neuroonkologie/NCT, Universität Heidelberg
🔹Led the KKE Neuroonkologie at DKFZ
🔹April 2006 – December 2006: Stellv. Ärztl. Direktor, Abt. Allgemeine
Neurologie, Universitätsklinik Tübingen
🔹Since October 2005: Member of the Steering Committee of the Hirntumorgruppe der
EORTC
🔹August 2004 – December 2006: Oberarzt für Neurologie
🔹April 2003: Facharztanerkennung für Neurologie (Recognition as a specialist in
Neurology)
🔹January 1998 – June 1999: AiP in the Abteilung Neurologie, Universität Tübingen
(with Prof. Dr. J. Dichgans)
🔹November 1997: Vorläufige Approbation (Provisional Medical License)
🔹June 1997 – November 1997: University of Bonn
🔹September 1996 – May 1997: Harvard Medical School, Boston, USA
🔹July 1994 – August 1996: University of Bonn
🔹September 1993 – June 1994: King's College London, GB
🔹October 1990 – August 1993: University of Bonn: Medizin (Medical studies)
🔹Primary
brain tumors (gliomas and lymphomas)
🔹Brain
metastases
🔹Neurological
complications of cancer
🔹Neuroimmunology
🔹Scientific Focus Areas:
🔹Targeted
anti-angiogenic therapy
🔹Immunotherapy
🔹Anti-invasive
therapy
🔹Stem
cells
